Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Plos One|February 5, 2016
MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal CarcinomaFabian Feiersinger, Elke Nolte, Sven Wach, et al.Molecular Oncology|November 3, 2025
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathwayArnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach-Wuensch, et al.Diagnostics (Basel, Switzerland)|January 8, 2023
NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict OutcomeMelanie Langheinrich, Alexander Reinhard Siebenhüner, Justus Baecker, et al.International Journal of Colorectal Disease|May 25, 2013
Expression and localization of axin 2 in colorectal carcinoma and its clinical implicationUte Schaal, Sandra Grenz, Susanne Merkel, et al.Oncogene|April 28, 2026
Fibroblast dynamics in colorectal cancer: stability, plasticity, and novel markersRichard Demmler, Charles G Anchang, Yongsong Yong, et al.Journal of Medical Imaging (Bellingham, Wash.)|March 18, 2022
Fast whole-slide cartography in colon cancer histology using superpixels and CNN classificationFrauke Wilm, Michaela Benz, Volker Bruns, et al.International Journal of Colorectal Disease|September 12, 2020
Colorectal cancer in Crohn's colitis is associated with advanced tumor invasion and a poorer survival compared with ulcerative colitis: a retrospective dual-center studyLeonie E Vetter, Susanne Merkel, Alan Bénard, et al.International Journal of Colorectal Disease|December 5, 2021
The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survivalFrancesco Vitali, Axel Wein, Timo Rath, et al.International Journal of Cancer|August 13, 2008
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapyElisabeth Naschberger, Roland S Croner, Susanne Merkel, et al.Gastroenterology|October 28, 2008
p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumorsStella Wassermann, Silvio K Scheel, Elke Hiendlmeyer, et al.Pageof 13